379 Epi-RTM P2 protocol produces a scalable polyclonal TIL product with a greater expansion success rate across hot and cold tumors in shorter culture time by Benjamin Harris, Suman Vodnala, Yogin Patel, Gary Lee, Shobha Potluri, Melissa Bedard, Carson Harms, Melissa DeFrancesco, Jaewon Yun, Saeed Azimi, Ngoc-Han Ha, Audrey Garces